SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-023923
Filing Date
2021-09-28
Accepted
2021-09-28 06:10:57
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1857763
2 ex31-1.htm EX-31.1 17715
3 ex31-2.htm EX-31.2 16733
4 ex32-1.htm EX-32.1 6138
  Complete submission text file 0001493152-21-023923.txt   7349724

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT obmp-20210630.xsd EX-101.SCH 51693
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT obmp-20210630_cal.xml EX-101.CAL 70502
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT obmp-20210630_def.xml EX-101.DEF 261698
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT obmp-20210630_lab.xml EX-101.LAB 454310
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT obmp-20210630_pre.xml EX-101.PRE 351337
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1016421
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 211283517
SIC: 2834 Pharmaceutical Preparations